• 10177 Citations
  • 52 h-Index
1983 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Bertolini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Neoplasms Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Italy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2019

  • 10177 Citations
  • 52 h-Index
  • 262 Article
  • 8 Chapter
  • 1 Editorial
  • 1 Letter

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

Sapienza, M. R., Abate, F., Melle, F., Orecchioni, S., Fuligni, F., Etebari, M., Tabanelli, V., Laginestra, M. A., Pileri, A., Motta, G., Rossi, M., Agostinelli, C., Sabattini, E., Pimpinelli, N., Truni, M., Falini, B., Cerroni, L., Talarico, G., Piccioni, R., Amente, S. & 11 others, Indio, V., Tarantino, G., Brundu, F., Paulli, M., Berti, E., Facchetti, F., Dellino, G. I., Bertolini, F., Tripodo, C., Rabadan, R. & Pileri, S. A., 2019, In : Haematologica. 104, 4, p. 729-737 9 p.

Research output: Contribution to journalArticle

Blastic plasmacytoid dendritic cell neoplasm: Genomics mark epigenetic dysregulation as a primary therapeutic target

Sapienza, M. R., Abate, F., Melle, F., Orecchioni, S., Fuligni, F., Etebari, M., Tabanelli, V., Laginestra, M. A., Pileri, A., Motta, G., Rossi, M., Agostinelli, C., Sabattini, E., Pimpinelli, N., Truni, M., Falini, B., Cerroni, L., Talarico, G., Piccioni, R., Amente, S. & 11 others, Indio, V., Tarantino, G., Brundu, F., Paulli, M., Berti, E., Facchetti, F., Dellino, G. I., Bertolini, F., Tripodo, C., Rabadan, R. & Pileri, S. A., 2019, In : Haematologica. 104, 4, p. 729-737 9 p.

Research output: Contribution to journalArticle

Genomics
Epigenomics
Dendritic Cells
Exome
Hematologic Neoplasms
1 Citation (Scopus)

Real-world efficacy and safety of lenvatinib: data from a compassionate use in the treatment of radioactive iodine-refractory differentiated thyroid cancer patients in Italy

Locati, L. D., Piovesan, A., Durante, C., Bregni, M., Castagna, M. G., Zovato, S., Giusti, M., Ibrahim, T., Puxeddu, E., Fedele, G., Pellegriti, G., Rinaldi, G., Giuffrida, D., Verderame, F., Bertolini, F., Bergamini, C., Nervo, A., Grani, G., Rizzati, S., Morelli, S. & 2 others, Puliafito, I. & Elisei, R., Sep 1 2019, In : European Journal of Cancer. 118, p. 35-40 6 p.

Research output: Contribution to journalArticle

Compassionate Use Trials
Thyroid Neoplasms
Iodine
Italy
Safety

The new small tyrosine-kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs

Soncini, D., Orecchioni, S., Ruberti, S., Minetto, P., Martinuzzi, C., Agnelli, L., Todoerti, K., Cagnetta, A., Miglino, M., Clavio, M., Contini, P., Varaldo, R., Bergamaschi, M., Guolo, F., Passalacqua, M., Nencioni, A., Monacelli, F., Gobbi, M., Neri, A., Abbadessa, G. & 5 others, Eathiraj, S., Schwartz, B., Bertolini, F., Lemoli, R. M. & Cea, M., Oct 17 2019, In : Haematologica.

Research output: Contribution to journalArticle

Myeloid Cells
Acute Myeloid Leukemia
Protein-Tyrosine Kinases
Neoplasms
Cell Survival

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

Sapienza, M. R., Abate, F., Melle, F., Orecchioni, S., Fuligni, F., Etebari, M., Tabanelli, V., Laginestra, M. A., Pileri, A., Motta, G., Rossi, M., Agostinelli, C., Sabattini, E., Pimpinelli, N., Truni, M., Falini, B., Cerroni, L., Talarico, G., Piccioni, R., Amente, S. & 11 others, Indio, V., Tarantino, G., Brundu, F., Paulli, M., Berti, E., Facchetti, F., Dellino, G. I., Bertolini, F., Tripodo, C., Rabadan, R. & Pileri, S. A., Oct 31 2018, In : Haematologica.

Research output: Contribution to journalArticle

Genomics
Epigenomics
Dendritic Cells
decitabine
Neoplasms